Ephedra Capsules

Produit de santé naturel homologué au Canada

Titulaire: Canadian Phytopharmaceuticals Corporation
NPN ou DIN-HM: 80047017
Statut: Licence active
Date de licence: 10 décembre 2013
Date de révision: Non renseignée
Forme: Capsule
Voie d'administration: Orale
Type de demande: Officinale

Si ce produit était vendu en France

Aucun point relevé par les règles que nous appliquons.

Une quantité quotidienne est calculée uniquement pour une posologie adulte orale explicite, exprimée par jour et dans une unité solide correspondant à la forme du produit. Les unités ambiguës, liquides, poudres et doses pédiatriques ne sont pas extrapolées. Une quantité non calculée n'est pas comparée aux limites de dose. Cette analyse ne constitue pas une autorisation de vente en France ni une évaluation de sécurité ou d'efficacité.

Composition

Ingrédient médicinal et source	Par unité posologique, selon la source	Par jour au plus, adulte
Ephedra sinica Source : Branchlet Puissance : 2 % l-Ephedrine	400 mg	Non calculée

Ingrédient médicinal et source

Par unité posologique, selon la source

Par jour au plus, adulte

Ephedra sinica

Source : Branchlet

Puissance : 2 % l-Ephedrine

400 mg

Non calculée

Ingrédients non médicinaux

Stéarate de magnésium, Maltodextrine

Doses recommandées au Canada

Population	Âge	Quantité par prise	Fréquence
Adultes	minimum : 19 ans	1 Capsule	minimum : 3 jours ; maximum : 4 jours

Usages autorisés au Canada

Used in Herbal Medicine as a decongestant/ to relieve nasal congestion. Used in Herbal Medicine as a decongestant/ to relieve nasal congestion (due to hay fever/allergic rhinitis/allergies). Used in Herbal Medicine as a decongestant/ to relieve nasal congestion (due to the common cold). Used in Herbal Medicine as a decongestant/ to relieve nasal congestion (due to sinusitis). Used in Herbal Medicine as a decongestant/ to relieve nasal congestion (due to flu).

Un usage autorisé au Canada n'est pas une allégation de santé autorisée dans l'Union européenne. Consultez le registre des allégations de santé.

Mises en garde au Canada

Contre-indications
Do not use if you are taking, or have taken in the past two weeks monoamine oxidase (MAO) inhibitors.
Précautions et mises en garde
Consult a health care practitioner if symptoms persist. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for allergy symptoms. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for asthma. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for cough/cold. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for weight control. Consult a health care practitioner prior to use if you are taking other products which contain caffeine. Consult a health care practitioner prior to use if you are taking other products which contain ephedrine. Consult a health care practitioner prior to use if you are taking other products which contain phenylpropanolamine. Consult a health care practitioner prior to use if you are taking other products which contain pseudoephedrine. Consult a health care practitioner prior to use if you have cardiovascular disease. Consult a health care practitioner prior to use if you have diabetes Consult a health care practitioner prior to use if you have difficulty in urination due to prostate enlargement. Consult a health care practitioner prior to use if you have glaucoma. Consult a health care practitioner prior to use if you have pre-existing psychiatric conditions. Consult a health care practitioner prior to use if you have seizure disorders. Consult a health care practitioner prior to use if you have thyroid problems. Keep out of reach of children.
Effets indésirables connus
Insomnia has been known to occur; in which case, discontinue use. Irritability, dizziness and/or tremor have been known to occur; in which case, discontinue use. Nausea and/or loss of appetite have been known to occur; in which case, discontinue use. Rapid heartbeat has been known to occur; in which case, discontinue use. Restlessness has been known to occur; in which case, discontinue use. Severe headache has been known to occur; in which case, discontinue use. Shortness of breath, and/or disturbance of urination have been known to occur; in which case, discontinue use.